Coulie Bernard
President And CEO
1 company
Insider Signal Score
80
ExcellentTrades Analyzed
27
12M Win Rate
100.0%
Avg 3M Return
+11.2%
Avg 12M Return
+43.1%
Coulie Bernard is a President And CEO at PLIANT THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $619K based on current market prices.
Holdings by Company
PLRXJan 20, 2026
Current Shares505.6K
Value$619.4K
Net Activity-650,926
Bought: 0Sold: 650.9K
Transaction History
Showing 10 filings (page 2)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | PLRX Pliant Therapeutics, Inc. | President And CEO | Sale+OE | 20,000 | $19.07 | $381,412.50 | -9.6% | +33.1% | -5.3% | |
| Jan 4, 2023 | PLRX Pliant Therapeutics, Inc. | President And CEO | Sale+OE | 30,000 | $19.20 | $575,892.00 | -13.8% | +35.0% | -0.6% | |
| Dec 20, 2022 | PLRX Pliant Therapeutics, Inc. | President And CEO | Sell | 34,212 | $19.10 | $653,531.31 | -26.7% | +45.1% | -14.4% | |
| Sep 12, 2022 | PLRX Pliant Therapeutics, Inc. | President And CEO | Sale+OE | 12,502 | $22.54 | $281,851.34 | -17.4% | -21.4% | -30.3% | |
| Jul 12, 2022 | PLRX Pliant Therapeutics, Inc. | President And CEO | Sale+OE | 27,498 | $22.50 | $618,705.00 | -18.8% | +10.2% | -6.6% | |
| Jun 14, 2021 | PLRX Pliant Therapeutics, Inc. | President And CEO | Sell | 4,000 | $33.03 | $132,102.38 | -0.4% | -42.7% | -78.9% | |
| May 14, 2021 | PLRX Pliant Therapeutics, Inc. | President And CEO | Sell | 3,500 | $28.64 | $100,224.44 | -0.4% | -25.4% | -82.5% | |
| Apr 14, 2021 | PLRX Pliant Therapeutics, Inc. | President And CEO | Sale+OE | 3,500 | $30.33 | $106,161.30 | -0.8% | -13.9% | -75.2% | |
| Mar 15, 2021 | PLRX Pliant Therapeutics, Inc. | President And CEO | Sell | 3,500 | $38.52 | $134,834.97 | -0.3% | -13.9% | -80.2% | |
| Feb 16, 2021 | PLRX Pliant Therapeutics, Inc. | President And CEO | Sell | 3,500 | $32.67 | $114,351.85 | -0.3% | - | - |